EPZM logo

Epizyme (EPZM) Cash From Investing

Annual CFI

$125.48 M
+$140.07 M+960.05%

December 31, 2021

Summary

Performance

1-Year Change

+960.05%

3-Year Change

+222.29%

5-Year Change

+10.72%

15-Year Change

+10.72%

EPZM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$125.48 M
EPZM annual cash flow from investing activities is currently at an all-time high

3-Year Low

$125.48 M
EPZM annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
EPZM previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
EPZM next annual earnings announcement has not yet been scheduled

OtherEPZMcash flowmetrics:

Annual CFF

$31.49 M
EPZM annual cash flow from financing activities is $31.49 million

Annual CFO

-$226.85 M
EPZM annual cash flow from operations is -$226.85 million

Annual FCF

-$227.34 M
EPZM annual free cash flow is -$227.34 million

Annual CAPEX

$486.00 K
EPZM annual capital expenditures is $486.00 thousand

Quarterly CFI

$48.71 M
+$92.90 M+210.23%

June 30, 2022

Summary

Performance

3-Month Change

+210.23%

1-Year Change

-20.12%

3-Year Change

+185.32%

5-Year Change

+16.74%

EPZM Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$86.27 M
EPZM quarterly cash flow from investing activities is currently -43.54% below its historical high of $86.27 million

3-Year Low

-$44.19 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
EPZM previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
EPZM next earnings announcement has not yet been scheduled

OtherEPZMcash flowmetrics:

Quarterly CFF

-$257.00 K
EPZM quarterly cash flow from financing activities is -$257.00 thousand

Quarterly CFO

-$54.81 M
EPZM quarterly cash flow from operations is -$54.81 million

Quarterly FCF

-$54.81 M
EPZM quarterly free cash flow is -$54.81 million

Quarterly CAPEX

$0.00
EPZM quarterly capital expenditures is $0.00

TTM CFI

$89.34 M
-$12.27 M-12.07%

June 30, 2022

Summary

Performance

3-Month Change

-12.07%

1-Year Change

+129.67%

3-Year Change

+204.72%

5-Year Change

+204.72%

EPZM TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$125.48 M
EPZM TTM cash flow from investing activities is currently -28.80% below its historical high of $125.48 million

3-Year Low

$89.34 M
EPZM TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
EPZM previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
EPZM next earnings announcement has not yet been scheduled

OtherEPZMcash flowmetrics:

TTM CFF

$110.16 M
EPZM TTM cash flow from financing activities is $110.16 million

TTM CFO

-$208.60 M
EPZM TTM cash flow from operations is -$208.60 million

TTM FCF

-$208.88 M
EPZM TTM free cash flow is -$208.88 million

TTM CAPEX

$275.00 K
EPZM TTM capital expenditures is $275.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

EPZM Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+960.0%-20.1%+129.7%
3 y3 years+222.3%+185.3%+204.7%
5 y5 years+10.7%+16.7%+204.7%

EPZM Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high-190.7%-28.8%at low
5 y5-yearat high-168.0%-26.9%-190.7%-28.8%-195.5%
alltimeall timeat high-231.8%-43.5%-510.0%-28.8%-323.5%

Epizyme Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2022
-
$48.71 M(-210.2%)
$89.34 M(-12.1%)
Mar 2022
-
-$44.19 M(-343.0%)
$101.61 M(-19.0%)
Dec 2021
$125.48 M(-960.1%)
$18.18 M(-72.7%)
$125.48 M(+42.9%)
Sep 2021
-
$66.64 M(+9.3%)
$87.82 M(+125.7%)
Jun 2021
-
$60.98 M(-400.1%)
$38.90 M(-171.5%)
Mar 2021
-
-$20.32 M(+4.3%)
-$54.42 M(+273.0%)
Dec 2020
-$14.59 M(-82.9%)
-$19.48 M(-209.9%)
-$14.59 M(-60.7%)
Sep 2020
-
$17.72 M(-154.8%)
-$37.15 M(-218.3%)
Jun 2020
-
-$32.35 M(-265.8%)
$31.39 M(+372.2%)
Mar 2020
-
$19.52 M(-146.4%)
$6.65 M(-107.8%)
Dec 2019
-$85.32 M(-16.8%)
-$42.04 M(-148.7%)
-$85.32 M(+4.0%)
Sep 2019
-
$86.27 M(-251.1%)
-$82.08 M(-39.1%)
Jun 2019
-
-$57.09 M(-21.2%)
-$134.69 M(+25.7%)
Mar 2019
-
-$72.45 M(+86.8%)
-$107.17 M(+4.5%)
Dec 2018
-$102.61 M(-190.5%)
-$38.80 M(-215.3%)
-$102.61 M(+285.1%)
Sep 2018
-
$33.65 M(-213.8%)
-$26.64 M(-38.3%)
Jun 2018
-
-$29.58 M(-56.4%)
-$43.16 M(-253.3%)
Mar 2018
-
-$67.88 M(-282.6%)
$28.15 M(-75.2%)
Dec 2017
$113.33 M
$37.17 M(+116.8%)
$113.33 M(+4.0%)
Sep 2017
-
$17.14 M(-58.9%)
$108.94 M(+16.7%)
Jun 2017
-
$41.73 M(+141.2%)
$93.37 M(-163.1%)
DateAnnualQuarterlyTTM
Mar 2017
-
$17.30 M(-47.2%)
-$148.05 M(-10.5%)
Dec 2016
-$165.41 M(+311.7%)
$32.78 M(+1996.0%)
-$165.41 M(-16.5%)
Sep 2016
-
$1.56 M(-100.8%)
-$198.19 M(-0.8%)
Jun 2016
-
-$199.69 M(>+9900.0%)
-$199.71 M(>+9900.0%)
Mar 2016
-
-$70.00 K(-1500.0%)
-$90.00 K(-99.8%)
Dec 2015
-$40.18 M(+1713.3%)
$5000.00(-87.8%)
-$40.18 M(-2.4%)
Sep 2015
-
$41.00 K(-162.1%)
-$41.17 M(-1.1%)
Jun 2015
-
-$66.00 K(-99.8%)
-$41.62 M(-1.1%)
Mar 2015
-
-$40.16 M(+3973.3%)
-$42.06 M(+1798.1%)
Dec 2014
-$2.22 M(+251.7%)
-$986.00 K(+142.9%)
-$2.22 M(+36.0%)
Sep 2014
-
-$406.00 K(-20.1%)
-$1.63 M(+33.2%)
Jun 2014
-
-$508.00 K(+60.8%)
-$1.22 M(+35.1%)
Mar 2014
-
-$316.00 K(-21.0%)
-$906.00 K(+43.8%)
Dec 2013
-$630.00 K(-56.4%)
-$400.00 K(<-9900.0%)
-$630.00 K(-56.1%)
Sep 2013
-
$0.00(-100.0%)
-$1.44 M(-0.5%)
Jun 2013
-
-$190.00 K(+375.0%)
-$1.44 M(+14.2%)
Mar 2013
-
-$40.00 K(-96.7%)
-$1.26 M(-12.5%)
Dec 2012
-$1.45 M(+57.4%)
-$1.21 M(>+9900.0%)
-$1.45 M(+504.6%)
Sep 2012
-
-$7000.00(-36.4%)
-$239.00 K(+3.0%)
Jun 2012
-
-$11.00 K(-95.0%)
-$232.00 K(+5.0%)
Mar 2012
-
-$221.00 K
-$221.00 K
Dec 2011
-$918.00 K
-
-

FAQ

  • What is Epizyme annual cash flow from investing activities?
  • What is the all time high annual CFI for Epizyme?
  • What is Epizyme annual CFI year-on-year change?
  • What is Epizyme quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Epizyme?
  • What is Epizyme quarterly CFI year-on-year change?
  • What is Epizyme TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Epizyme?
  • What is Epizyme TTM CFI year-on-year change?

What is Epizyme annual cash flow from investing activities?

The current annual CFI of EPZM is $125.48 M

What is the all time high annual CFI for Epizyme?

Epizyme all-time high annual cash flow from investing activities is $125.48 M

What is Epizyme annual CFI year-on-year change?

Over the past year, EPZM annual cash flow from investing activities has changed by +$140.07 M (+960.05%)

What is Epizyme quarterly cash flow from investing activities?

The current quarterly CFI of EPZM is $48.71 M

What is the all time high quarterly CFI for Epizyme?

Epizyme all-time high quarterly cash flow from investing activities is $86.27 M

What is Epizyme quarterly CFI year-on-year change?

Over the past year, EPZM quarterly cash flow from investing activities has changed by -$12.27 M (-20.12%)

What is Epizyme TTM cash flow from investing activities?

The current TTM CFI of EPZM is $89.34 M

What is the all time high TTM CFI for Epizyme?

Epizyme all-time high TTM cash flow from investing activities is $125.48 M

What is Epizyme TTM CFI year-on-year change?

Over the past year, EPZM TTM cash flow from investing activities has changed by +$50.44 M (+129.67%)